Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens

The Veterinary Journal
Xia XiaoYa-Hong Liu

Abstract

Pharmacokinetic and pharmacodynamic (PK/PD) indices against Mycoplasma gallisepticum (MG) S6 were investigated in an ex vivo PK/PD model following oral administration of valnemulin to chickens co-infected with M. gallisepticum and Escherichia coli. The minimum inhibitory concentrations (MICs) for valnemulin against MG S6 in artificial medium and chicken serum were determined. In vitro time-killing curves were established according to a series of multiples of the MIC value in an artificial medium, and ex vivo time-killing curves were established in serum samples obtained from infected chickens at different time points after oral administration with an initial titer of 1 × 10(6) color change units (CCU)/mL MG S6. The sigmoid Emax model was used to provide 24 h area under concentration-time curve/minimum inhibitory concentration ratios (AUC0-24h/MIC) for mycoplasmastasis, mycoplasmacidal activity and mycoplasmal elimination, respectively. The inoculum size and micro or macro methods exhibited little effect on MIC determination of MG, whereas matrix had a large effect. The rapid killing activity observed in in vitro time-killing curves seems to indicate that valnemulin was mycoplasmacidal and concentration dependent against MG. The...Continue Reading

References

Mar 1, 1988·The Journal of Antimicrobial Chemotherapy·J A RobertsonD E Taylor
Jun 7, 2003·Journal of Clinical Microbiology·M KarlssonA Franklin
Sep 9, 2005·Avian Pathology : Journal of the W.V.P.A·D R Mekkes, A Feberwee
Feb 2, 2006·Avian Pathology : Journal of the W.V.P.A·A FeberweeJ A Stegeman
Jul 26, 2006·Pharmacotherapy·Warren E Rose, Michael J Rybak
Dec 30, 2006·Veterinary Microbiology·Anne Kruse LykkebergLars Bogø Jensen
Oct 24, 2007·Infection and Immunity·Gunther VoglMichael P Szostak
May 15, 2009·Biological Reviews of the Cambridge Philosophical Society·Clare McW H BenskinIan R Hartley
Mar 9, 2011·Veterinary Microbiology·Saad Gharaibeh, Mohammad Al-Rashdan
Apr 16, 2011·Journal of Veterinary Pharmacology and Therapeutics·R WangY H Liu
Dec 24, 2011·Annals of the New York Academy of Sciences·Rodger Novak
Jul 3, 2013·The Veterinary Journal·John D MitchellDeclan J McKeever
Nov 23, 2013·Animal Science Journal = Nihon Chikusan Gakkaihō·Kazuhiro KawaiToshio Oshida

❮ Previous
Next ❯

Citations

May 21, 2016·Frontiers in Microbiology·Nan ZhangHuanzhong Ding
Aug 21, 2016·BMC Veterinary Research·Dénes GróznerMiklós Gyuranecz
Oct 1, 2019·Journal of Veterinary Science·Wanhe LuoShuyu Xie
Dec 18, 2020·Frontiers in Veterinary Science·Sara T ElazabWalter H Hsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.